FDA approves new pill to reduce pain from endometriosis

July 24, 2018 by Linda A. Johnson
FDA approves new pill to reduce pain from endometriosis
This undated image provided by AbbVie in July 2018 shows packaging for the company's drug Orilissa (elagolix). On Tuesday, July 24, 2018, the company said that The Food and Drug Administration approved its the drug for pain during menstruation and at other times. (AbbVie via AP)

A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators.

The common condition involves abnormal tissue growth from the uterus that can cause and infertility.

Drugmaker Abbvie said the Food and Drug Administration approved the drug, Orilissa, for pain during menstruation and intercourse and at other times. Abbvie says it's the first new pill for endometriosis in a decade.

In testing, it significantly reduced in about 45 percent of women given a low dose and 75 percent given a high dose, compared to about 20 percent of women given dummy pills. Reduction of pain outside menstruation was slightly lower.

The drug works by reducing production of the . That caused side effects in some participants, including hot flashes, headaches and bone thinning.

Orilissa will cost $845 every four weeks, without insurance.

An estimated 1 in 10 women of reproductive age has endometriosis. Treatment usually begins with over-the-counter pain relievers, opioid painkillers and . Other options include injections of hormone-suppressing drugs, which have significant side effects, and surgery.

The new pill provides more flexible dosing in lowering estrogen levels, according to Dr. Hugh Taylor of Yale-New Haven Hospital. A consultant to AbbVie, he helped lead key studies of Orilissa.

Explore further: Are you ignoring endometriosis?

Related Stories

Are you ignoring endometriosis?

May 25, 2018
(HealthDay)—Endometriosis is a painful condition affecting many women, yet often years pass before it's diagnosed.

Lower-, higher-dose elagolix beneficial for endometriosis

May 22, 2017
(HealthDay)—Lower- and higher-dose elagolix are beneficial for women with endometriosis, according to research published online May 19 in the New England Journal of Medicine to coincide with the 13th World Congress on Endometriosis, ...

Pregnancy doesn't 'cure' endometriosis, so where does this advice come from?

December 18, 2017
Many Australian women with endometriosis are reporting they're being advised a reliable treatment or even possible cure for their endometriosis is to "go away and have a baby". This message is consistent with what women from ...

It's OK to skip your period while on the pill

May 17, 2018
The pill is the most common form of contraception in Australia, with up to 60% of young women choosing this option to prevent pregnancy.

Study tests potential new drug to reduce pain and symptoms of endometriosis

October 9, 2012
(Medical Xpress)—According to the Centers for Disease Control (CDC), endometriosis, a gynecological disorder in which cells from the uterus lining grow in other areas of the body, is the number one reason for a hysterectomy ...

Low-dose 'pill' linked to pain during orgasm, study finds

May 3, 2013
(HealthDay)—Women taking birth control pills with lower amounts of estrogen—a commonly prescribed contraceptive—may be at higher risk for chronic pelvic pain and pain during orgasm, according to new research.

Recommended for you

Blood test may identify gestational diabetes risk in first trimester

August 16, 2018
A blood test conducted as early as the 10th week of pregnancy may help identify women at risk for gestational diabetes, a pregnancy-related condition that poses potentially serious health risks for mothers and infants, according ...

Artificial placenta created in the laboratory

August 14, 2018
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at Vienna University of Technology (Vienna) have succeeded in creating an artificial placental barrier on a ...

The inequalities of prenatal stress

August 14, 2018
Exposure to an acute stress in utero can have long-term consequences extending into childhood – but only among children in poor households, according to a new Stanford study that looked at the long-term impact of acute, ...

Better studies needed on effectiveness of fertility awareness-based methods for contraception

August 10, 2018
A new systematic review provides the most comprehensive assessment to date on the scientific evidence estimating the effectiveness of various fertility awareness-based methods (FABMs) for contraception. "Effectiveness of ...

Inducing labor at 39 weeks reduces likelihood of C-sections

August 8, 2018
Inducing labor in healthy first-time mothers in the 39th week of pregnancy results in lower rates of cesarean sections compared with waiting for labor to begin naturally at full term, according to a multicenter study funded ...

Three-dimensional model of human placenta developed

August 3, 2018
The placenta is the organ connecting mother and embryo. Its main functions are the exchange of nutrients, gases and metabolic products and the production of hormones and other substances essential for embryonic development. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.